https://www.selleckchem.com/pr....oducts/alflutinib-as
nts, or adenoviral type 6 titers at screening. CONCLUSION Our results suggest the safety and feasibility of V934/V935 hTERT vaccination in cancer patients with solid tumors Trial Registration Name of the registry ClinicalTrial.gov Trial registration number NCT00753415 Date of registration 16 September 2008 Retrospectively registered URL of trial registry record https//clinicaltrials.gov/ct2/results?cond=term=NCT00753415cntry=state=city=dist=.BACKGROUND Several small cross-sectional studies ha
Curtir
Comentario
Compartilhar
